1036 related articles for article (PubMed ID: 15958243)
1. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
2. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
3. Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing.
Liu Y; Cai S; Shu XZ; Shelby J; Prestwich GD
Wound Repair Regen; 2007; 15(2):245-51. PubMed ID: 17352757
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
5. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
6. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds.
Andreopoulos FM; Persaud I
Biomaterials; 2006 Apr; 27(11):2468-76. PubMed ID: 16321436
[TBL] [Abstract][Full Text] [Related]
7. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
Peattie RA; Rieke ER; Hewett EM; Fisher RJ; Shu XZ; Prestwich GD
Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
[TBL] [Abstract][Full Text] [Related]
8. Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules.
Tae G; Kim YJ; Choi WI; Kim M; Stayton PS; Hoffman AS
Biomacromolecules; 2007 Jun; 8(6):1979-86. PubMed ID: 17511500
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2).
Liu LS; Ng CK; Thompson AY; Poser JW; Spiro RC
J Biomed Mater Res; 2002 Oct; 62(1):128-35. PubMed ID: 12124794
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
11. Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels.
McGonigle JS; Tae G; Stayton PS; Hoffman AS; Scatena M
J Biomater Sci Polym Ed; 2008; 19(8):1021-34. PubMed ID: 18644228
[TBL] [Abstract][Full Text] [Related]
12. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration.
DeLong SA; Moon JJ; West JL
Biomaterials; 2005 Jun; 26(16):3227-34. PubMed ID: 15603817
[TBL] [Abstract][Full Text] [Related]
13. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
[TBL] [Abstract][Full Text] [Related]
14. Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury.
Tsurkan MV; Hauser PV; Zieris A; Carvalhosa R; Bussolati B; Freudenberg U; Camussi G; Werner C
J Control Release; 2013 May; 167(3):248-55. PubMed ID: 23395667
[TBL] [Abstract][Full Text] [Related]
15. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor.
Mi FL; Shyu SS; Peng CK; Wu YB; Sung HW; Wang PS; Huang CC
J Biomed Mater Res A; 2006 Jan; 76(1):1-15. PubMed ID: 16224775
[TBL] [Abstract][Full Text] [Related]
17. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering.
Shu XZ; Ahmad S; Liu Y; Prestwich GD
J Biomed Mater Res A; 2006 Dec; 79(4):902-12. PubMed ID: 16941590
[TBL] [Abstract][Full Text] [Related]
19. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
20. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
Lee F; Chung JE; Kurisawa M
J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
